Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > I am assuming that the
View:
Post by Oden6570 on Jul 28, 2023 12:38am

I am assuming that the

Next news we get from TLT is quarterly update end of August.  Perhaps we get suprising news prior to then but summer tends to be a very quiet time for most companies.
Comment by StevenBirch on Jul 28, 2023 8:11am
Yes summer will be over, more data, more time lapsed for BTD/AA to be approved. Also, I read an article today about preparedness for the NEXT pandemic with a 'made in Canada' vaccine so while everything seems to take a long time we are definitely in the right place with TLT, maybe we get some news on that front in the fall.
Comment by 99942Apophis on Jul 28, 2023 10:16am
Unfortunately Theralase appears not to have any forward movement in the vaccine battle.  TLT may only be one of many that could be a future consideration  Feb 12, 2023 — Health Canada has authorized the use of Medicago, a plant-based COVID-19. 00:52. Health Canada authorizes plant-based COVID vaccine.
Comment by Rumpl3StiltSkin on Jul 29, 2023 7:55am
I think TLTs bacterium/virii portfolio is important tech that some pharma will want. It is summer so we probably won't hear anything new until end of Aug. Would be a waste if we get big news now...
Comment by Johnandrose22 on Jul 29, 2023 12:14pm
Agree'd...The company's ongoing pursuit to complete a patent for the bacterium/virus technology indicates, to me, that they still see this as having significant value. How significant is yet to be known. John
Comment by Bigkahuna57 on Jul 30, 2023 1:52pm
I'm not the SME on vaccines or Medicago, but found this while trying to confirm the details of this email.  FYI IMO. https://www.ctvnews.ca/health/coronavirus/canadian-covid-19-vaccine-manufacturer-medicago-inc-shutting-down-1.6258785 It would appear Medicago is shutting down, not going to be a source for a vaccine.   Anyone have additional thoughts? Good luck to all ...more  
Comment by 99942Apophis on Jul 30, 2023 3:55pm
Yes Bigkahuna57 and 9 days later Canada Health declared it as a Canadian Covid-19 vaccine which would if produced be out of its parent company Mitsubishi but seems unlikely. At its best their vaccine could only achieve a 71% . Question arises as IF Theralase will have something ready for next year , I just think its too late for this years winter Flu season. 
Comment by Galaxym31 on Jul 31, 2023 1:27pm
Yes good luck and sweet dreams . Maybe have a look at Medicina a Canadian cancer fighter doing a phase 3 trial on brain cancer . MC 39 million US .
Comment by Pandora on Jul 30, 2023 6:00pm
https://stockhouse.com/news/press-releases/2023/07/27/zentek-and-mcmaster-university-announce-new-aptamer-technology-platform ???
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250